Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
First MedTech company moves in at The London Cancer Hub’s Innovation Gateway
Precision medicine start-up enterprise Vesynta has become the first MedTech company to move into a sophisticated laboratory at south London’s newest incubator space, the Innovation Gateway at The London Cancer Hub in Sutton.
PhD student Rose Foster wins ICR Science and Medical Imaging Competition
PhD student Rose Foster in the Prostate and Bladder Cancer Team in the Division of Radiotherapy and Imaging has won the ICR Science and Medical Imaging Competition 2022 for her image of a fluorescent image of bladder tumour tissue.
‘Junk’ DNA could lead to cancer by stopping copying of DNA
Scientists have found that non-coding ‘junk’ DNA, far from being harmless and inert, could potentially contribute to the development of cancer.
Pioneering ICR scientist wins prestigious translational cancer research award
Dr George Poulogiannis, leader of the Signalling and Cancer Metabolism Team at The Institute of Cancer Research, London, has received the 2022 British Association of Cancer Research–AstraZeneca Young Scientist Frank Rose Award for his research into the role of metabolism and nutrition in cancer development and therapy response.
Researchers call for improved use of chemical tools to enhance biomedical research
Experts in biomedical research are calling for better use of chemical probes to improve our understanding of protein function and the foundations on which much of modern drug discovery and development are based.
Scientists discover mechanism controlling spread of pancreatic cancer
Scientists have shown it is possible to reverse a key process that allows pancreatic cancer cells to grow and spread around the body.
ICR remembers Dame Deborah James
The ICR has offered heartfelt condolences to Dame Deborah James' family after the campaigner and podcaster very sadly died - Deborah had been living with bowel cancer for six years.
EMA recommends olaparib for treatment of high-risk, early breast cancer
The Institute of Cancer Research, London, strongly welcomes the news that olaparib has been recommended by the European Medicines Agency (EMA) to treat people with high-risk, early-stage breast cancer who have inherited faults in their BRCA1 or BRCA2 genes.
ICR among top-ranked universities for invention income for ninth consecutive year
The Institute of Cancer Research, London, has again ranked among the top academic institutions in the UK at generating income from its intellectual property.
Light-activated ‘photoimmunotherapy’ could enhance brain cancer treatment
An innovative light-activated therapy developed at The Institute of Cancer Research, London, could help detect and treat an aggressive brain cancer type, a new study shows.
New combination therapy exploits ‘natural killer’ cells to destroy head and neck tumours
Scientists have identified a new treatment combination that is highly effective at suppressing the growth of head and neck tumours.
ICR Discovery Club showcases how we combine therapies to target hard-to-treat cancers
Discovery Club members gathered at the Science Museum in London to learn how our researchers are transforming cancer care for patients with innovative combination therapies.